Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

NCT02804815 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

11000

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Gastro-oesophageal Cancer

Interventions

DRUG: Aspirin 100mg
DRUG: Aspirin 300mg
DRUG: Placebo 100mg
DRUG: Placebo 300mg

Sponsor

University College, London